Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan 6;8(2):10.2202/1557-4679.1354 /j/ijb.2012.8.issue-2/1557-4679.1354/1557-4679.1354.xml.
doi: 10.2202/1557-4679.1354.

Causal inference for vaccine effects on infectiousness

Affiliations

Causal inference for vaccine effects on infectiousness

M Elizabeth Halloran et al. Int J Biostat. .

Abstract

If a vaccine does not protect individuals completely against infection, it could still reduce infectiousness of infected vaccinated individuals to others. Typically, vaccine efficacy for infectiousness is estimated based on contrasts between the transmission risk to susceptible individuals from infected vaccinated individuals compared with that from infected unvaccinated individuals. Such estimates are problematic, however, because they are subject to selection bias and do not have a causal interpretation. Here, we develop causal estimands for vaccine efficacy for infectiousness for four different scenarios of populations of transmission units of size two. These causal estimands incorporate both principal stratification, based on the joint potential infection outcomes under vaccine and control, and interference between individuals within transmission units. In the most general scenario, both individuals can be exposed to infection outside the transmission unit and both can be assigned either vaccine or control. The three other scenarios are special cases of the general scenario where only one individual is exposed outside the transmission unit or can be assigned vaccine. The causal estimands for vaccine efficacy for infectiousness are well defined only within certain principal strata and, in general, are identifiable only with strong unverifiable assumptions. Nonetheless, the observed data do provide some information, and we derive large sample bounds on the causal vaccine efficacy for infectiousness estimands. An example of the type of data observed in a study to estimate vaccine efficacy for infectiousness is analyzed in the causal inference framework we developed.

PubMed Disclaimer

References

    1. Becker N, Britton T, O'Neill P. Estimating vaccine effects from studies of outbreaks in household pairs. Stat Med. 2006;25:1079–1093. - PubMed
    1. Black H, Shinefeld B, Fireman S, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187–195. - PubMed
    1. Cisse B, Aaby P, Simondon F, Samb B, Soumaré M, Whittle H. Role of schools in the transmission of measles in rural Senegal: Implications for measles control in developing countries. Am J Epidemiol. 1999;149:295–301. - PubMed
    1. Clemens, Sack DA, Harris J, et al. J. Field trial of oral cholera vaccines. Lancet. 1986;2:124–7. - PubMed
    1. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Jul 18; 10.1056/NEJMoa1105243, published online at NEJM.org. - PMC - PubMed

Publication types